North America Stroke Management Market Size, Analysis, Growth

North America Stroke Management Market By Type (Diagnostics - Computed Tomography Scan, Magnetic Resonance Imaging, Echocardiography, Carotid Ultrasound, Cerebral Angiography, Electrocardiography; Therapeutics - Tissue Plasminogen Activator, Anticoagulant, Antiplatelet), Application (Ischemic, Haemorrhagic)

Published Date: December-2017 | Number of Pages: 82 | Format: PDF | Report ID: KBV-693

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


COVID-19

Get in-depth analysis of the COVID-19 impact on the North America Stroke Management Market

Market Report Description

The North America Stroke Management Market would witness market growth of 6.8% CAGR during the forecast period (2018 – 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth. Rising investments to upgrade healthcare systems and demand for technologically advanced devices for rapid & accurate distribution of medicines are the factors that are driving the market in the region. Research and development activities in the region would further add to the market attractiveness in the region.

Click Here For Free Insights

Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.

Scope of the Study

Market Segmentation:

By Type

  • Diagnostics
  • Computed Tomography Scan (CT Scan)
  • Magnetic Resonance Imaging (MRI)
  • Echocardiography
  • Carotid Ultrasound
  • Cerebral Angiography
  • Electrocardiography
  • Others
  • Therapeutics
  • Tissue Plasminogen Activator
  • Anticoagulant
  • Antiplatelet
  • Other Therapeutics Type

By Application                                                  

  • Ischemic Stroke
  • Hemorrhagic Stroke

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • ABBOTT Laboratories
  • B. Braun Melsungen Ag
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Ge Healthcare
  • Glaxosmithkline Plc
  • Medtronic Plc
  • Siemens Aktiengesellschaft
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Stroke Management Market

Europe Stroke Management Market

Asia Pacific Stroke Management Market

LAMEA Stroke Management Market

 

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities